ArticleJournal of breast cancer2022

Ceramide Synthase 6 Mediates Triple-Negative Breast Cancer Response to Chemotherapy Through RhoA- and EGFR-Mediated Signaling Pathways.

Hui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.